Method of treating hematologic tumors and cancers using beta lapachone

Details for Australian Patent Application No. 2002248229 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Gupta, Deepak; Li, Youzhi; Pardee, Arthur, B.; Anderson, Kenneth; Li, Chiang

Agent Cullen & Co

Pub. Number AU-B-2002248229

PCT Pub. Number WO2002/058694

Priority 60/246,552 07.11.00 US

Filing date 7 November 2001

Wipo publication date 6 August 2002

Acceptance publication date 30 November 2006

International Classifications

A61K 31/32 (2006.01)

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248229

30 November 2006 Application Accepted

  Published as AU-B-2002248229

29 March 2007 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248230-NUCLEIC ACID DETECTION USING STRUCTURED PROBES

2002248228-Methods and apparatus for securely transmitting and processing digital image data